Virtus LifeSci Biotech Clinical Trials ETF (BBC) Short Interest Ratio & Short Volume

Short interest is the volume of Virtus LifeSci Biotech Clinical Trials ETF shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 26,200 shares of BBC short. 3.74% of Virtus LifeSci Biotech Clinical Trials ETF's shares are currently sold short. Learn More on Virtus LifeSci Biotech Clinical Trials ETF's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BBC shares currently have a short interest ratio of 1.0. Learn More on Virtus LifeSci Biotech Clinical Trials ETF's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.74% of Virtus LifeSci Biotech Clinical Trials ETF's floating shares are currently sold short.

Virtus LifeSci Biotech Clinical Trials ETF saw a increase in short interest in the month of July. As of July 31st, there was short interest totaling 26,200 shares, an increase of 359.6% from the previous total of 5,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

3.74% of Virtus LifeSci Biotech Clinical Trials ETF's shares are currently sold short. Here is how the short interest of companies compare to Virtus LifeSci Biotech Clinical Trials ETF: First Trust Nasdaq Pharmaceuticals ETF (0.02%), Harbor Health Care ETF (0.38%), Direxion Daily Pharmaceutical & Medical Bull 3X Shares (3.33%), JPMorgan Healthcare Leaders ETF (0.07%), Virtus LifeSci Biotech Products ETF (1.70%), Langar Global HealthTech ETF (0.40%), ProShares UltraShort Nasdaq Biotechnology (7.47%), ProShares UltraShort Health Care (3.87%), Invesco Nasdaq Biotechnology ETF (0.57%), ProShares Ultra Nasdaq Biotechnology (0.88%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), MicroStrategy Incorporated ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

Short selling BBC is an investing strategy that aims to generate trading profit from Virtus LifeSci Biotech Clinical Trials ETF as its price is falling. BBC shares are trading up $0.38 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Virtus LifeSci Biotech Clinical Trials ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BBC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BBC, twice per month. The most recent reporting period available is July, 31 2025.